Holm, 2001, Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients, Am J Cardiol, 87, 815, 10.1016/S0002-9149(00)01516-2
Laufs, 2000, Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription, Circulation, 102, 3104, 10.1161/01.CIR.102.25.3104
Lefer, 2002, Statins as potent antiinflammatory drugs, Circulation, 106, 2041, 10.1161/01.CIR.0000033635.42612.88
Albert, 2001, Effect of statin therapy on C-reactive protein levels, JAMA, 286, 64, 10.1001/jama.286.1.64
Mitchell, 2003, Are lipid-lowering drugs also antiarrhythmic drugs? An analysis of the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, J Am Coll Cardiol, 42, 81, 10.1016/S0735-1097(03)00498-4
Anderson, 2003, Lipid-lowering therapy for prevention of ventricular tachyarrhythmias, J Am Coll Cardiol, 42, 88, 10.1016/S0735-1097(03)00497-2
Young-Xu, 2003, Statins reduce the incidence of atrial fibrillation in patients with coronary artery disease, J Am Coll Cardiol, 41, 301A, 10.1016/S0735-1097(03)82411-7
Dernellis, 2001, C-reactive protein and paroxysmal atrial fibrillation, Acta Cardiol, 56, 375, 10.2143/AC.56.6.2005701
Chung, 2001, C-reactive protein elevation in patients with atrial arrhythmias, Circulation, 104, 2886, 10.1161/hc4901.101760
Takahashi, 2001, Atrial fibrillation impairs endothelial function of forearm vessels in humans, J Card Fail, 7, 45, 10.1054/jcaf.2001.22107
Conway, 2002, Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation, Circulation, 106, 1962, 10.1161/01.CIR.0000033220.97592.9A
Cai, 2002, Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation, Circulation, 106, 2854, 10.1161/01.CIR.0000039327.11661.16